NMRA-GRIN2A

N/A

Report date: 2024/11/25 16:53:35
NME

Base Information

Drug NameNMRA-GRIN2A
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionGlutamate receptor ionotropic, NMDA 2A modulators
TargetsGlutamate receptor ionotropic, NMDA 2A
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeumora Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeumora Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A